Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.38 |
| ▸ | FEN1 | P39748 | 2/20 | 0.38 |
| ▸ | PIP4K2A | P48426 | 4/20 | 0.38 |
| ▸ | PIP4K2B | P78356 | 4/20 | 0.38 |
| ▸ | PIP4K2C | Q8TBX8 | 1/20 | 0.38 |
| ▸ | ATR | Q13535 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.36 |
| ▸ | CLK1 | P49759 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16508276 | 0.88 | MET (0.40) | NPC1JAK2RAB9ACYP3A4ALOX5AP | |
| SCHEMBL16508269 | 0.88 | ALOX5AP (0.45) | NPC1JAK2RAB9ACYP3A4ALOX5AP | |
| SCHEMBL1702674 | 0.85 | CYP3A4 (0.45) | NPC1JAK2RAB9ACYP3A4KDM4E | |
| SCHEMBL16508294 | 0.84 | CYP3A4 (0.41) | CYP3A4KDM4EALDH1A1LMNAHSP90AA1 | |
| SCHEMBL16508271 | 0.78 | CYP3A4 (0.46) | JAK2CYP3A4KDM4EALDH1A1LMNA | |
| SCHEMBL3765201 | 0.74 | ALOX5AP (0.45) | NPC1JAK2RAB9ACYP3A4ALOX5AP | |
| SCHEMBL1703319 | 0.74 | MET (0.40) | NPC1JAK2RAB9ACYP3A4ALOX5AP | |
| SCHEMBL16508293 | 0.74 | TDO2 (0.42) | — | |
| SCHEMBL16508295 | 0.73 | CYP3A4 (0.49) | CYP3A4PIP4K2APIP4K2BPIP4K2CMAPK10 | |
| SCHEMBL15188916 | 0.73 | CYP3A4 (0.49) | JAK2CYP3A4KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110300103-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | ROCHE PALO ALTO LLC (US) | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110300103-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | EIF2AK2, ZC3HAV1, IRF3 | NPC1 1579/4885JAK2 276/4885RAB9A 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.